Moderna Loses European COVID Vaccine Patent in Dispute With Pfizer, BioNTech

Published on November 22, 2023

The European Patent Office has invalidated one of Moderna’s patents for its mRNA-based COVID-19 vaccine, handing a win to the vaccine giant’s German competitor, BioNTech. The patent in question, listed as EP3718565 in the European Patent Register, protects “respiratory virus vaccines,” according to its listing. Those opposing the patent include BioNTech, its partner Pfizer, and French pharmaceutical company Sanofi. BioNTech on Tuesday confirmed the news, saying it “understands and welcomes” the European authority’s decision to declare the patent invalid. “The European Patent Office’s decision is an important one as we believe that this and others of Moderna’s patents do not meet the requirements for grant and should never have been granted,” it added....